Integrated Diagnostics Holdings (CHIX:IDHCL) Accounts Payable & Accrued Expense : $16.37 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Integrated Diagnostics Holdings Accounts Payable & Accrued Expense?

Integrated Diagnostics Holdings's quarterly accounts payable & accrued expense declined from Mar. 2024 ($13.44 Mil) to Jun. 2024 ($13.39 Mil) but then increased from Jun. 2024 ($13.39 Mil) to Dec. 2024 ($16.37 Mil).

Integrated Diagnostics Holdings's annual accounts payable & accrued expense declined from Dec. 2022 ($22.40 Mil) to Dec. 2023 ($16.27 Mil) but then increased from Dec. 2023 ($16.27 Mil) to Dec. 2024 ($16.37 Mil).

Integrated Diagnostics Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Integrated Diagnostics Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Accounts Payable & Accrued Expense Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

31.22

59.84

22.40

16.27

16.37

Integrated Diagnostics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															19.92	16.27	13.44	13.39	16.37

Integrated Diagnostics Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Integrated Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (CHIX:IDHCl) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IDGXF:USA IDHC:UK

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, the Contract Segment, which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings Headlines

No Headlines